Billionaire Nelson Peltz Joins Aurora Cannabis as Strategic Adviser

Billionaire investor Nelson Peltz is joining Aurora Cannabis Inc. as a strategic adviser and is receiving stock options that could make him the pot firm’s second-largest shareholder.

Peltz, whose New York-based Trian Fund Management LP has more than $10 billion under management, will advise Aurora on potential partnerships, the company said in a statement Wednesday. Aurora’s shares gained 8.5 percent to C$11.54 as of 10:43 a.m. in Toronto. Continue reading “Billionaire Nelson Peltz Joins Aurora Cannabis as Strategic Adviser”

Coca-Cola Is Eyeing the Cannabis Market

The world’s largest beverage company may be the next industry giant to jump into the cannabis drinks business.

Coca-Cola Co. says it’s monitoring the nascent industry and is interested in CBD — the non-psychoactive ingredient in marijuana — for beverages as soda consumption slows. The Atlanta-based soft drinks maker is in talks with Canadian marijuana producer Aurora Cannabis Inc. to develop the drinks, according to a report from BNN Bloomberg Television. Continue reading “Coca-Cola Is Eyeing the Cannabis Market”

TGOD and Aurora Cannabis Extend Agreement

The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”)(TSX:TGOD)(US:TGODF) announces it has agreed with Aurora Cannabis Inc. (“Aurora”) (TSX:ACB) to extend Aurora’s exercise deadline of its first milestone option (the “Milestone Option”) under the TGOD Aurora Investor Rights Agreement by 6 weeks to October 12, 2018. The first Milestone Option entitles Aurora to acquire an additional 8% of the common shares of the Company. Continue reading “TGOD and Aurora Cannabis Extend Agreement”

CanniMed Deal Sparks Aurora Cannabis Inc (OTCMKTS:ACBFF)

Aurora Cannabis Inc (OTCMKTS:ACBFF) has continued to make new highs in recent action, fueled in part by its recent success in landing the deal it has been seeking in a takeover of CanniMed. The news helped push the stock to a new intraday all-time high around $12.30/share. However, ACBFF closed lower to end the week and pulled back in a typical sell-the-news move. Continue reading “CanniMed Deal Sparks Aurora Cannabis Inc (OTCMKTS:ACBFF)”

Aurora Cannabis To Buy CanniMed Therapeutics For $1.1 Billion

Aurora Cannabis Inc. has struck a friendly deal valued at $1.1 billion to buy rival licensed producer CanniMed Therapeutics Inc., ending a hostile takeover battle between the Canadian marijuana companies.

“We are very pleased to have come to terms with CanniMed on this powerful strategic combination that will establish a best-in-class cannabis company with operations across Canada and around the world,” Aurora chief executive Terry Booth said. Continue reading “Aurora Cannabis To Buy CanniMed Therapeutics For $1.1 Billion”